The experience of diagnosing Alzheimer’s disease based on the study of cerebrospinal fluid biomarkers
The high frequency of AD CSF biomarkers in both the classical (amnesic) and atypical phenotypes is shown. This indicates the need to expand the use of AD CSF biomarkers for a more reliable assessment of the prevalence of AD In Russia.
Authors
- С. Н. Иллариошкин (ORCID: https://orcid.org/0000-0002-2704-6282)
- E. Yu. Fedotova (ORCID: https://orcid.org/0000-0001-8070-7644)
- Yu. A. Shpilyukova (ORCID: https://orcid.org/0000-0001-7214-583X)
- А. А. Шабалина (ORCID: https://orcid.org/0000-0001-9604-7775)
- A. G. Burmak (ORCID: https://orcid.org/0000-0002-7523-2928)
- Kseniya Nevzorova (ORCID: https://orcid.org/0009-0000-9148-0203)
Institutions
- Research Center of Neurology (RU)
Publication Details
- Journal
- S S Korsakov Journal of Neurology and Psychiatry
- Published
- 2025-02-11
- DOI
- https://doi.org/10.17116/jnevro202512501191
- Citations
- 2
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 2.94